Media headlines about Pro-Dex (NASDAQ:PDEX) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm rates the sentiment of news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Pro-Dex earned a media sentiment score of 0.17 on Accern’s scale. Accern also assigned media coverage about the medical instruments supplier an impact score of 45.4875280582287 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Pro-Dex stock traded up $0.11 during mid-day trading on Monday, hitting $6.96. 7,312 shares of the company were exchanged, compared to its average volume of 8,260. Pro-Dex has a 1-year low of $4.30 and a 1-year high of $8.00.
COPYRIGHT VIOLATION NOTICE: “Pro-Dex (PDEX) Receiving Somewhat Favorable Press Coverage, Report Finds” was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this story on another website, it was illegally stolen and republished in violation of US & international copyright and trademark law. The correct version of this story can be read at https://www.dispatchtribunal.com/2018/04/09/pro-dex-pdex-receiving-somewhat-favorable-press-coverage-report-finds.html.
Pro-Dex Company Profile
Pro-Dex, Inc (Pro-Dex) designs and produces surgical and dental instruments and motion control products used in the medical, factory automation and scientific research industries. The Company operates through four segments: Pro-Dex, OMS, Fineline and Engineering Services Division (ESD). The Pro-Dex segment provides primarily medical and dental instruments using shared production and assembly machines and workforce.
Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.